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ABSTRACT 
Salmonella typhimurium is a leading cause of infectious human gastroenteritis and 
systemic disease when it escapes into the bloodstream. The human serum complement 
system is central in fighting systemic bacterial infections. S. typhimurium exhibits resistance 
to killing by complement (serum-resistance), a trait conferred by several known virulence 
genes. This study investigates a potential chromosomal complement-resistance gene in S. 
typhimurium tagged by TnphoA insertional transposon mutagenesis. S. typhimurium strain 
EM876 has a chromosomal TnphoA insertion and reduced serum-resistance. Inverse PCR 
and subsequent DNA sequence analysis reveal the insertion to be in the gene glpQ. glpQ 
codes for a periplasmic glycerophosphodiester phosphodiesterase involved in glycerol 
degradation. Complementation assays using a clone of glpQ on a multicopy plasmid are 
consistent with a role for glpQ in serum-resistance. glpQ is preferentially expressed at 37°C 
versus 30°C. This is similar to traT and suggests that multiple temperature-regulated genes 
may contribute to serum-resistance in S. typhimurium. 
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INTRODUCTION 
Function of complement as an immune defense 
Human serum contains various proteins, the main purpose of which is to eliminate 
bacteria. The most important serum proteins in this regard are those of the complement 
system, a central element of the innate immune response in humans. The complement system 
is composed of a complex network of soluble serum proteins which, when activated, interact 
to kill microbes (26). Complement can be activated via three separate pathways:  the classical 
(CCP), lectin (LCP), and alternative complement pathways (ACP) (26). Different early 
complement proteins are produced by each pathway, but the three pathways converge into 
one when the protein C3 is cleaved into C3a and C3b (26). C3a remains unbound in serum 
and acts as a chemokine for immune system mediators of inflammation. C3b opsonizes both 
gram-negative and gram-positive bacteria, binding to bacterial cell surfaces to mark them for 
phagocytosis. It also cleaves the next molecule in the cascade, C5, into C5a and C5b. C5b 
leads to the activation of C6, C7, C8, and many C9 molecules that form a complex, which 
inserts into the cell membranes of gram-negative bacteria. This complex forms a pore called 
the Membrane Attack Complex (MAC). MAC kills the bacterial cell by depolarizing the cell 
membrane (40). 
The complement system cannot function properly as part of innate immunity without 
regulation. Both membrane-bound and soluble regulatory proteins work to prevent host 
tissues from becoming damaged by complement attack (26). Factor H is a soluble regulator 
that prevents inappropriate activation of the ACP. C4bp is another soluble regulator that 
binds to the early complement protein C4b and prevents it from initiating the cleavage of C3 
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into C3a and C3b (6). Binding of C4bp to C4b inhibits activation of the CCP and LCP.  
Bound regulators include a protein called CD59, which hinders assembly of the MAC (26). 
Bacterial evasion of complement  
Complement evasion is the major determinant of serum-resistance, since the 
bactericidal action of serum for gram-negative bacteria such as S. typhimurium is due mostly 
to the action of complement (42). Bacteria have a number of different mechanisms by which 
they can avoid opsonophagocytosis or lysis by complement. The lipopolysaccharide (LPS) of 
gram-negative bacteria contains O-antigen chains that can physically prevent components of 
complement from accessing the bacterial cell surface (8). Bacteria that are coated with sialic 
acids, like the host, can prevent activation of the ACP through binding of complement 
regulatory proteins (40). 
The capsules of both gram-negative and gram-positive bacteria can prevent 
opsonization. C3b gets buried too deep in the capsule and cannot be detected by the receptors 
on phagocytic cells. Similarly, gram-positive bacteria are not lysed by complement because 
their thick cell walls prevent the MAC from reaching the bacterial cell membrane (40).  
Genes associated with complement-resistance in Salmonella 
Salmonella typhimurium is a facultative intracellular pathogen. It is a major causative 
agent of food-borne gastroenteritis in humans and a severe typhoid-like systemic infection in 
mice. Salmonella preferentially lives and reproduces within macrophages in a specialized 
compartment called the Salmonella-containing vesicle. When Salmonella is released from the 
macrophage, however, it can survive and replicate in the bloodstream (39). The presence of 
bacteria in the bloodstream, bacteremia, distributes Salmonella throughout the body, 
initiating a systemic infection that can be quite severe, especially in immunocompromised 
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individuals. Resistance to complement is essential to the extracellular survival and 
dissemination of Salmonella. A number of different genes have been identified that play a 
role in serum-resistance. 
rck  is a gene on the virulence plasmid of S. typhimurium that encodes the outer 
membrane protein Rck. Rck prevents C9 from polymerizing correctly, and the MAC cannot 
form as a result (19-21).  Ail is an outer membrane protein of Yersinia enterocolitica that is 
homologous to Rck and it has been shown by Biedzka-Sarek et al. (3) to bind the regulator of 
the ACP, Factor H.  Ail has also been shown to bind C4bp, which regulates both the CCP 
and LCP (25). The homology between Ail and Rck suggests that Rck may have a similar 
ability to use host complement regulators as shields against complement attack. 
rsk is a small (66 bp long) region of the S. typhimurium virulence plasmid that was 
found to restore serum-resistance to strains made serum-sensitive due to chromosomal 
integration of the virulence plasmid. This region is too small to encode a protein, but 
VandenBosch et al. (43) suggest that it may be a regulatory protein-binding site or enable 
some other mechanism of interfering with complement regulators, enhancing bacterial 
survival in serum. 
 wzzST and wzzfepE are both chromosomal genes that regulate the length of LPS 
components: long O-antigen polysaccharides (L-Oag) with 16-35 O-antigen repeat units and 
very long O-antigen polysaccharides (VL-Oag) with more than 100 O-antigen repeat units, 
respectively. L-Oag and VL-Oag work in concert to prevent activation of the CCP by 
concealing the antigenic Lipid A domain of the LPS (33). They also physically prevent 
complement from reaching the bacterial cell membrane (8). 
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The gene traT, located on the virulence plasmid of S. typhimurium and a conjugative 
plasmid of Escherichia coli, is also responsible for serum-resistance. The primary role of 
TraT is to prevent conjugative transfer of genetic material. However, cells containing the 
traT gene are also protected from complement-mediated killing (41). Pramoonjago et al. (35) 
showed that the traT encoded cell wall protein, TraT, prevents C5b6 complex formation and 
assembly of the MAC on the surface of bacterial cells.   
pagC is a chromosomal gene that encodes for the outer membrane protein PagC in 
Salmonella choleraesuis and S. typhimurium. PagC belongs to a family of outer membrane 
proteins that includes Rck in S. typhimurium and Ail in Yersinia enterocolitica. While it 
shows a high level of amino acid sequence homology with Rck, the mechanism by which it 
promotes serum-resistance remains unclear (34).  
PgtE is a chromosomally encoded surface protease that cleaves complement proteins 
C3b, C4b, and C5 (38). When Salmonella is still contained within macrophages, changes in 
the structure of LPS result in a decrease in the amount and length of O-antigen chains (39). 
Shortened O-antigen chains make the cell wall accessible to complement components 
including the MAC in the extracellular environment. Ramu et al. (39) proposed S. 
typhimurium uses the PgtE protease as an alternative mechanism of complement evasion 
when it is released from macrophages.  
Investigation of thermoregulated serum-resistance genes 
In previous work conducted by this laboratory, TnphoA mutagenesis was employed to 
identify temperature-dependent genes encoding serum-resistance in S. typhimurium (46). 
Like many genes that encode virulence traits (30), serum-resistance appears to be 
temperature-regulated in S. typhimurium (46). Virulence is also highly associated with 
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exported proteins and, therefore, TnphoA is more likely to create functional insertions in 
virulence genes than other types of genes (30). TnphoA is a transposable element that can 
form gene fusions, providing a way to identify proteins (and the genes encoding these 
proteins) that are exported from the cytoplasm of the cell. The 5’ end of the phoA gene is 
truncated to remove its signal sequence. Alkaline phosphatase (PhoA) can only be expressed 
if TnphoA inserts into the coding sequence of a gene for an exported protein, downstream of 
the gene’s own native promoter and signal sequence, and in-frame with translation (24, 31). 
Since it was found that S. typhimurium is more resistant to complement at 37°C than at 30°C, 
more than 500 TnphoA insertion mutants were screened for temperature-regulated genes 
exhibiting increased sensitivity to human serum. The screen was carried out by growing 
isolates at both 37°C and 30°C and measuring the PhoA activity for each isolate at both 
growth temperatures. Four mutants were found that had increased PhoA expression at 37°C, 
had decreased survival in serum, and had no reduction in growth rate in decomplemented 
serum. Three of them had mutations that mapped to the traT gene located on the 95 kb 
virulence plasmid (46). The fourth (EM876) had a mutation that mapped to the chromosome, 
but was not further investigated at that time. 
The purpose of the current study is to identify the chromosomal gene disrupted by 
TnphoA that we predict to function in serum-resistance. If the TnphoA insertional mutation in 
strain EM876 is indeed responsible for the temperature-sensitive phenotype, then addition of 
a normal gene to the mutant strain will restore serum-resistance. Therefore, this study 
identified the site of the insertion, cloned the wild-type gene, and tested for the ability of the 
cloned wild-type gene to complement the mutant. 
 6 
MATERIALS AND METHODS 
Bacterial Strains and Plasmids 
All strains of S. typhimurium and E. coli used in this study are listed in Table 1. 
CR6600 is a virulent human isolate and CR8500 is a virulent avian isolate of a different 
biotype than CR6600. Both of these wild-type strains have been described previously (23). E. 
coli strain DH5αλpir and S. typhimurium strain JS198 were obtained from James Slauch 
(University of Illinois, Urbana-Champaign), and both express the Pi protein necessary for 
conditional replication of the lambda Red vectors. Strains EM1261 – EM1300 were 
generated during the course of the current study. All plasmids used in this study are listed in 
Table 2. Plasmids pKD3, pKD46, and pCP20, were obtained from James Slauch. Primer 
DNA sequences are listed in Table 3.  
Table 1.  List of Bacterial Strains Used in This Study 
Strain Species Description Source/Reference 
CR6600 S. typhimurium TML wild-type (human isolate) (23) 
CR8500 S. typhimurium S850 FIRN wild-type (avian isolate) (23) 
CR7020 S. typhimurium S850 StrR (44) 
LB5010 S. typhimurium hsdLT (r-m+), hsdSA (r-m+), hsdSB (r-m+), 
metA22, metE551, trpD2, leu, val, rpsL120, 
galE 
(10) 
EM876 S. typhimurium glpQ::TnphoA fusion (46) 
EM518 S. typhimurium EM876 and EM1830 parent strain (46) 
EM1830 S. typhimurium TnphoA fusion in an unidentified gene (46) 
EM1235 S. typhimurium EM876/pLX9610 this study 
DH5αλpir E. coli endA1, hsdR17, supE44, thi-1, recA1, gyrA, 
relA1, DEL(lac-argF)U169, deoR ϕ80, 
(15) 
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Δ(lac)M15, λ pir+ / pKD3 
JM109 E. coli endA1, recA1, gyrA96, thi, hsdR17 (rk–, 
mk+), relA1, supE44, Δ( lac-proAB), [F´ 
traD36, proAB, laqIqZΔM15] 
Promega 
JS198 S. typhimurium LT2, metE55,1 metA2,2 ilv452, trpB2, 
hisC527(am), galE496, xyl-404, rpsL120, 
flaA66, hsdL6, hsdSA29, zjg8103::pir+ 
recA1 
(15) 
EM1261 S. typhimurium JS198/pKD46 this study 
EM1270 S. typhimurium S850/pKD46 this study 
EM1271 S. typhimurium TML/pKD46 this study 
EM1282 S. typhimurium JS198 ΔglpQ::cat this study 
EM1287 S. typhimurium S850 ΔglpQ::cat (a). P22 transductant from 
EM1282 
this study 
EM1289 S. typhimurium S850 ΔglpQ::cat (c). P22 transductant from 
EM1282 
this study 
EM1290 S. typhimurium TML ΔglpQ::cat (d). P22 transductant from 
EM1282 
this study 
EM1292 S. typhimurium TML ΔglpQ::cat (f). P22 transductant from 
EM1282 
this study 
EM1293 S. typhimurium S850 ΔglpQ (a) this study 
EM1294 S. typhimurium S850 ΔglpQ (c) this study 
EM1295 S. typhimurium TML ΔglpQ (d) this study 
EM1296 S. typhimurium TML ΔglpQ (f) this study 
EM1297 S. typhimurium S850 ΔglpQ (a)/pLX9610 this study 
EM1298 S. typhimurium S850 ΔglpQ (c)/pLX9610 this study 
EM1299 S. typhimurium TML ΔglpQ (d)/pLX9610 this study 
EM1300 S. typhimurium TML ΔglpQ (f)/pLX9610 this study 
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Table 2. List of Plasmids Used in This Study 
Plasmid Description Source/Reference 
pGEM-T Easy TA cloning and sequencing vector Promega 
pAM1110 pGEM-T Easy::Mogull inverse PCR product this study 
pBB2208 pGEM-T Easy::Rahme inverse PCR product this study 
pBH2011 pGEM-T Easy::Purdy inverse PCR product this study 
pLX9610 pGEM-T Easy::glpTQ this study 
pKD3 Pi-dependent lambda Red template plasmid, with 
FRT flanked cat cassette 
(14) 
pKD46 Red recombinase expression plasmid (14) 
pCP20 Flippase (FLP) helper plasmid (13) 
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Table 3. Primer Sequences Used in This Study 
 
Primer Sequence (5’-3’) Source 
Mogull 1 CAAAACGGGAAAGGTTCCG (32) 
Mogull 2 GCTCTGCGTGATTCTCTTAGCG (32) 
Rahme 1 AATATCGCCCTGAGCAGC (37) 
Rahme 2 AATACACTCACTATGCGCTG (37) 
Purdy 1 ATATCGCCCTGAGCAG (36) 
Purdy 2 CAACCGGTGTCAAAACC (36) 
glpTQ 
forward GGTATCGCCTTATTGCCAGA this study 
glpTQ 
reverse AATGTTTGATTTCGCGCATA this study 
glpQ H1P1 TGAGGCGTTTATGCCCTCATCCGGCGCGTCACTTCGA- 
CTATGGCAAACCTTGTAGGCTGGAGCTGCTTCG this study 
glpQ H2P2 AAAACGCCATCATGATGAGCTGCAGTTAAAACGCAAC- 
GGAGGCTAATAACCATATGAATATCCTCCTTAG this study 
c1 TTATACGCAAGGCGACAAGG (14) 
c2 GATCTTCCGTCACAGGTAGG (14) 
glpQ ko 
forward CCGGCGCGTCACTTCGACTAT this study 
glpQ ko 
reverse GCTGCAGTTAAAACGCAACGGAG this study 
glpQ int 
forward TTCCGCCACCTGCTTCATAG this study 
glpQ int 
reverse CTGATTTCCGCATTCATACCTTTG this study 
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Culture Conditions 
Luria-Bertani (LB) broth and agar plates (Acumedia, Neogen Corporation, Lansing, 
MI) were used for routine growth and maintenance of S. typhimurium and E. coli strains at 
37°C, unless otherwise indicated. The following antibiotics were used as appropriate: 
streptomycin, 500 µg/ml; kanamycin, 50 µg/ml; ampicillin, 100 µg/ml; chloramphenicol, 30 
µg/ml. 
Chemicals, Enzymes, and Reagents 
Antibiotics and p-nitrophenyl phosphate (pNPP) substrate were purchased from 
Sigma (St. Louis, MO). Isopropyl-beta-D-thiogalactopyranoside (IPTG) and 5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside (X-gal) were purchased from Gold Biotechnology 
(St. Louis, MO). L-arabinose was obtained from EMD Chemicals, Inc. (San Diego, CA). 
Sodium dodecyl sulfate (SDS) as well as miscellaneous media additives were obtained from 
Gibco BRL (Carlsbad, CA). GelRed DNA stain was purchased from Biotium, Inc. (Hayward, 
CA). Restriction enzymes and Taq polymerase were purchased from New England BioLabs, 
Inc. (NEB; Ipswich, MA), unless otherwise noted. 
DNA Preparation 
All genomic DNA was prepared using the Qiagen DNeasy Blood & Tissue kit 
(Valencia, CA). Plasmid DNA was prepared using the PureYield™ Plasmid Miniprep 
System (Promega, Madison, WI). All kits were used according to manufacturer’s directions. 
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Other Genetic/Molecular Methods 
PCR - PCR primers in this study were designed using the program Primer 3 
(http://primer3.sourceforge.net/) and synthesized by Integrated DNA Technologies, Inc. 
(Coralville, IA).  
Competent Cell Preparation – Electrocompetent cell preparation was adapted from 
the method described by Maloy et al. (30). Overnight cultures were diluted 1:100 in fresh 
Super Optimal Broth (SOB) medium (18) and incubated at 37°C with aeration until they 
reached mid to late log phase (OD600 = 0.6 – 0.8). Cultures were transferred to 50 ml conical 
tubes, cooled on ice for 15 minutes, then centrifuged at 2450 x g for 10 minutes at 4°C. Cells 
were suspended in 0.2 volumes ice-cold sterile deionized water, then centrifuged at 2450 x g 
for 10 minutes at 4°C. Cells were washed two additional times with 0.1 volumes, then 0.02 
volumes ice-cold sterile deionized water. Cells then were suspended in 0.01 volumes ice-cold 
10% (v/v) glycerol, transferred to 1.5 ml tubes, and centrifuged at 6000 x g for 5 minutes. 
Cells were suspended one last time in 0.01 volumes ice-cold 10% glycerol, aliquoted into 
chilled 1.5 ml tubes, and frozen at -80°C until ready for use. 
Transformation – Chemically competent JM109 E. coli were purchased from 
Promega and transformed via heat shock according to the manufacturer’s instructions. 
Electrocompetent cells were transformed via electroporation using a Gene Pulser apparatus 
(Bio-Rad, Hercules, CA) as follows.  40 µl cells were mixed with 1-2 µl DNA in a sterile 
microcentrifuge tube on ice and then transferred to a chilled 0.2 cm electroporation cuvette. 
Cells were shocked in a Gene Pulser (Bio-Rad) set at 25 µF, 200 Ω, and 2.5 kV for 4.7 msec. 
Recovery was in 1 ml Super Optimal Catabolite-repression (SOC) medium (18) with aeration 
(200 rpm) at 37°C for 1 hour. 
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DNA Sequencing and Sequence Analysis – DNA sequencing was performed on an 
Applied Biosystems 3730 XL sequencer at the University of Michigan DNA Sequencing 
Core (http://seqcore.brcf.med.umich.edu/). Standard premade SP6 and T7 sequencing 
primers, provided by the sequencing core, were used on mini-prep plasmid template DNA.  
Nucleotide searches of the GenBank database were performed using the BLASTN 
algorithm (1). MacVector 9.0 (Cary, NC) was used for ClustalW alignments, sequence 
annotation, and to generate sequence graphics.  
Agarose Gel Electrophoresis – Agarose gel electrophoresis was performed with either 
sodium borate or lithium borate buffers as described previously (9). Gels were composed of 
1% - 2% agarose with GelRed DNA stain (Biotium) added prior to melting. The 1 Kb Plus 
DNA Ladder from Invitrogen (Carlsbad, CA) was used to estimate the molecular weight of 
DNA fragments, however, exact DNA fragment sizes were determined from sequence data. 
Blue/Orange Loading Dye, 6X (Promega) was added to DNA prior to loading samples onto 
agarose gels. Gels were UV visualized and photographed using a Gel Doc™ XR+ System 
(Bio-Rad). 
Statistical Analysis 
Statistical analyses of data were performed using the computer software program 
JMP, Version 9.0.2, SAS Institute, Inc., Cary, NC, 1989-2011. One-way analysis of variance 
(ANOVA) was performed with Dunnett’s multiple comparison testing against a control 
group. Significance was accepted at p<0.05. 
Identifying Location of TnphoA Insertion 
The location of the TnphoA insertion in mutant EM876 was determined by inverse 
PCR as previously described (32). In brief, chromosomal DNA was digested by the 
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restriction enzyme TaqI, which has a site located 403 bp downstream of the 5’ end of 
TnphoA. The resulting DNA fragments were circularized by T4 DNA ligase. PCR was 
performed using three separate sets of primers, Mogull (32), Rahme (37), and Purdy (36), 
listed in Table 3. The primers are specific to TnphoA and face away from one another to 
amplify the unknown sequence adjoining TnphoA. GoTaq® Green Hot Start Master Mix 
(Promega) was used with 1 µM of each of the forward and reverse primers and 
approximately 10 ng of TaqI-digested circularized DNA. The following PCR conditions were 
used: initial 2 min incubation at 94°C, followed by 30 cycles (94°C for 1 min, 51°C for 1 
min, 72°C for 1 min), with a final extension at 72°C for 5 min. The PCR products were gel-
purified using Zymoclean™ Gel DNA Recovery Kit (Zymo Research, Irvine, CA) and 
ligated into pGEM-T Easy to create plasmids pAM1110, pBB2208, and pBH2011 that were 
transformed into E.coli strain JM109 for blue/white screening. Gel purification and ligation 
into pGEM-T easy were both done according to the manufacturer’s instructions. Plasmid 
DNA from each of the above-mentioned plasmids was isolated from several white colonies 
and sequenced. For each plasmid, BLASTN analysis of sequence data revealed the site of the 
TnphoA insertion to be the chromosomal gene, glpQ, which encodes a periplasmic 
glycerophosphodiester phosphodiesterase. 
Cloning of glpQ 
glpQ is the promoter distal gene in the glpTQ operon. The promoter proximal gene, 
glpT, encodes a glycerol-3-P permease. The entire glpTQ operon (including the native 
promoter and regulatory binding sites; Figure 3) of S. typhimurium strain CR8500 was PCR 
amplified using 1 unit Phusion™ High-Fidelity DNA Polymerase (NEB, Ipswich, MA), 200 
ng chromosomal DNA isolated from wild-type strain CR8500, 0.2 µM of each of the primers 
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glpTQ forward and glpTQ reverse (Table 3.), 200 µM deoxyribonucleotide triphosphate 
(dNTP) mixture, and 1x Phusion™ HF Buffer. PCR conditions include an initial 2 min 
denaturation at 98°C, followed by 30 cycles (98°C for 10 s, 59.8°C for 30 s, 72°C for 1 min 
30 s). PCR products were purified with DNA Clean & Concentrator™-5 (Zymo Research). 
Deoxyadenosine triphosphates (dATPs) were added to the 3’ end of the PCR products to 
allow for ligation into pGEM-T Easy. In brief, GoTaq® Green Hot Start Master Mix 
(Promega) was incubated with purified PCR products as follows: denaturation at 94°C for 2 
minutes, followed by extension at 72°C for 30 minutes. Once the PCR products were A-
tailed, they were cloned into pGEM-T Easy, creating complementation plasmid, pLX9610. 
The construct was confirmed by DNA sequencing. 
Construction of Recombinant Strains 
glpQ deletions in S. typhimurium CR8500 and CR6600 were made using the lambda 
Red system, as described by Datsenko and Wanner (14). The procedure would replace glpQ 
with an antibiotic resistance cassette that has flippase recognition target (FRT) sites for easy 
removal later on, as shown in Figure 6. Seventy-nucleotide primers, glpQ H1P1 and glpQ 
H2P2 (Table 3), made up of 50 bp of homologous glpQ flanking sequences, H1 and H2, plus 
20 bases of primer extensions, P1 and P2, were used to PCR amplify the FRT-cat cassette out 
of plasmid pKD3. PCR was conducted using 1.25 units OneTaq™ Hot Start DNA 
Polymerase (NEB) with 1 unit Phusion™ High-Fidelity DNA Polymerase (NEB), 1x 
OneTaq Standard Reaction Buffer, 200 µM dNTP mixture, 0.2 µM of each primer, and 
approximately 1.5 ng pKD3 plasmid DNA. PCR conditions were as follows: initial 
denaturation at 94°C for 30 s, followed by 35 cycles (94°C for 20 s, 67°C for 40 s, 68°C for 2 
min), and a final extension at 68°C for 5 min. The 1100 base pair amplicon was then purified 
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and concentrated using the Wizard® SV Gel and PCR Clean-Up System (Promega) 
according to product instructions. 
The plasmid pKD46 is under the control of a temperature-sensitive origin of 
replication, and expression of the Red recombinase genes is controlled by an arabinose 
promoter. Strains harboring this plasmid must be propagated and maintained at 30°C, and 
recombinase activity is only induced by adding L-arabinose to the growth medium (14). 
Twenty-four ng pKD46 was transformed into 40 µl freshly prepared competent S. 
typhimurium strains CR8500, CR6600, and JS198. Recovery was 1.5 hours at 30°C in 1 ml 
SOC medium with aeration (200 rpm). Cultures were spread on LB ampicillin plates and 
incubated overnight at 30°C. Several transformants of each strain were colony purified, 
plasmid DNA was isolated, and the presence of pKD46 was verified by restriction analysis 
with EcoRI. EcoRI cuts pKD46 into two fragments of 4820 and 1509 bp, respectively. 
Agarose gel electrophoresis showed the expected bands in all strains tested.  
Strains bearing pKD46 were made competent and Red recombinase expression was 
induced with L-arabinose in the following manner. Overnight cultures, grown in SOB with 
ampicillin, were diluted 1:100 into fresh SOB containing ampicillin and 100 mM L-
arabinose. Control (non-induced) strains were grown in the same way, except without 
addition of arabinose. Cultures were incubated in a rotary shaker set at 175 rpm and 30°C for 
3 hours 40 minutes until they reached mid to late log phase (OD600 = 0.6-0.8). At this point, 
cultures were made competent as usual and stored at -80°C until ready for use. 
824 ng of the PCR product, consisting of the amplified FRT-cat cassette with glpQ 
homology extensions, was transformed into both arabinose-induced and non-induced 
CR8500, CR6600, and JS198 strains containing pKD46. Transformants were recovered in 
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SOC, with aeration, at 37°C for 3 hours. During the recovery process, the Red recombinase, 
which was induced with arabinose earlier, promotes homologous recombination between the 
homology extensions of the PCR product and the corresponding region on the chromosome. 
Once recombination has taken place, glpQ is replaced by the FRT-cat cassette.  After 
recovery, cells were pelleted and suspended in 200 µl of fresh SOC. 100 µl were plated on 
LB plates containing 10 µg/ml chloramphenicol and incubated overnight at 37°C.  
Transformants were streaked onto fresh chloramphenicol plates and PCR screened for 
replacement of glpQ with the FRT-cat cassette using primers designed to amplify the 5’ 
junction fragment, glpQ ko forward and c1 (Table 3), which produces a 247 bp fragment. 
Agarose gel electrophoresis was performed on the PCR products, and several isolates of each 
strain that had a band at 247 bp were chosen for further analysis. The isolates were colony 
purified and re-streaked several times on plain LB plates at 42°C to eliminate plasmid 
pKD46, which encodes ampicillin-resistance. 
Because the Red recombinase can cause unwanted recombination events, the glpQ 
deletions were moved from S. typhimurium strain EM1282 (JS198 ΔglpQ::cat) into clean 
CR8500 (S850) and CR6600 (TML) backgrounds by P22 HT int transduction (30).  
Transductants (EM1287, EM1289, EM1290, and EM1292) were made competent and 
transformed with the temperature-sensitive plasmid, pCP20. The flippase encoded by pCP20 
recognizes the FRT sites flanking the chloramphenicol marker and removes the marker. The 
plasmid and the antibiotic resistance marker are simultaneously cured from the transductants 
by passaging at 42°C, resulting in S850 ΔglpQ strains EM1293 and EM1294 and TML 
ΔglpQ strains EM1295 and EM1296, which were now ready for complementation. The 
deletion of glpQ was confirmed by PCR using primers, glpQ ko fwd and glpQ ko rev (Table 
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3), designed to amplify glpQ and its flanking regions. PCR products were analyzed via gel 
electrophoresis and visualization. 
The above-mentioned glpQ deletion strains were made competent and complemented 
by transformation of plasmid pLX9610, which carries the glpTQ operon, resulting in strains 
EM1297, EM1298, EM1299, and EM1300. 
Alkaline Phosphatase Assays 
The temperature-dependence of glpQ gene expression was assessed by alkaline 
phosphatase assays on S. typhimurium strain EM876 with the TnphoA insertion in glpQ (30). 
EM876 cultures were grown overnight at both 30°C and at 37°C in L broth supplemented 
with 50 µg/ml kanamycin. 1.5 ml aliquots of culture were washed once in 750 µl of 
phosphate buffered saline (PBS; BD/Difco, Franklin Lakes, NJ), then suspended in an equal 
volume of PBS. 200 µl cells were added to 1700 µl assay buffer, pH 10.1 (30 mM Na2CO3, 
20 mM NaHCO3, 0.005% SDS, and saturated with chloroform), then 200 µl of 0.4% pNPP in 
glycine buffer (0.1 M glycine, 1 mM ZnCl2, 1 mM MgCl2, pH 10.4) was added to the cell 
suspension. Alkaline phosphatase production was quantified spectrophotometrically by 
absorbance at 410 nm and normalized against cell density absorbance at 570 nm. Absorbance 
readings were taken every 30 minutes for several hours. Normalized alkaline phosphatase 
activity was determined by the following formula:  
phoA Activity = (A410 – k A570) / A570 
k is a proportionality constant experimentally determined by the ratio A410 / A570. In this case, 
k = 1.95. 
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Alkaline phosphatase expression was determined by the ratio of phoA activity at 37°C 
to phoA activity at 30°C. Higher ratios indicate that cultures grown at 37°C had more 
alkaline phosphatase expression than the same cultures grown at 30°C. 
Serum Killing Assays 
Unless otherwise noted, pooled normal human sera (PNHS) purchased from Sigma 
(catalog number S1764) were used for serum killing assays. 18-hour cultures were grown 
with aeration at 37°C and diluted in either PBS or Veronal-buffered saline with 1% gelatin 
(VBSG; Sigma). The diluted culture was inoculated into PNHS to a final concentration of 
about 1 x 105 cfu/ml and 90% PNHS. Time 0 samples of the mixture were taken and plated 
in triplicate on tryptic soy agar (TSA; Acumedia). The culture/serum mix was then incubated 
at 37°C with 5% CO2 to maintain the appropriate pH. Samples were plated again at 2 hours 
and 6 hours post-inoculation. Serum killing was determined by percent survival (viable 
counts) at 2 hours and 6 hours compared with the initial plating at time 0. Serum sensitivity 
of mutants was determined by comparing percent survival with that of the parent strains. 
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RESULTS 
Determination of TnphoA Insertion Site 
Inverse PCR was conducted using primers described by Mogull et al., Rahme et al., 
and Purdy et al. in order to amplify the gene disrupted by TnphoA (32, 36, 37). Three primer 
sets were used to increase the likelihood of isolating this gene.  Each primer set produced a 
DNA fragment of a different size, as shown in Figure 1. Inverse PCR involves digesting 
TnphoA-containing genomic DNA with a restriction enzyme and then circularizing the 
resulting DNA fragments with T4 DNA ligase. The primers are outward facing and specific 
to TnphoA and should be able to amplify a stretch of unknown DNA sequence adjacent to it 
since all of the DNA fragments are circularized. The restriction enzyme chosen was TaqI, 
which has a cut site in TnphoA 403 bp downstream from the 5’ end of the transposon (32). 
 
 
Figure 1. Inverse PCR products with TnphoA-based primers analyzed on a 1.2% agarose 
gel. The 1 Kb Plus DNA ladder (Invitrogen) was used to estimate the molecular weight of 
the bands. Amplicon size was determined from sequence analysis. 
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Sequence Analysis of Inverse PCR Products 
Once inverse PCR products were gel-purified and cloned into pGEM-T Easy 
(Promega), one representative isolate from each primer set was sent out for DNA sequencing. 
Sequences were compared to the GenBank database using the BLASTN algorithm and 
aligned with the gene glpQ. ClustalW analysis of the inverse PCR fragments revealed the 
location of the glpQ::TnphoA fusion (Figure 2). As shown in Figure 3, glpQ is the distal gene 
of the glpTQ operon, with both promoter elements and binding sites for the gene regulators 
CRP, GlpR, and FNR upstream of the first gene in the operon, glpT  (1, 4). 
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Figure 2.  Detail of the 5' TnphoA junction with glpQ. The graphic of the junction 
sequence shows the location of the fusion of glpQ to phoA. The underlined nucleotides 
represent the signal sequence for glpQ, which is upstream of the gene fusion. 
Cloning of glpQ 
In order to clone glpQ for complementation, DNA primers were designed to PCR 
amplify the region from approximately 200 bases upstream of glpT to 200 bases beyond the 
transcriptional end of glpQ. This was done to ensure that the necessary promoter elements 
and regulatory regions were also amplified along with glpQ. The resulting amplicon was 
nearly 3000 bp, which is longer than the standard Taq polymerase could effectively amplify. 
Therefore, PCR was done using Phusion™  polymerase (NEB), which has high processivity 
as well as 3’ to 5’ proofreading ability. Phusion™  polymerase can amplify long DNA 
templates, but results in blunt-ended products that are not suitable for TA-cloning because of 
the lack of 3’ A-overhangs. To address this issue, dATPs were added to the 3’ ends of the 
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glpTQ amplicon as described in Materials and Methods. This amplicon was TA-cloned into 
pGEM-T Easy (Promega) to create the complementation plasmid, pLX9610. 
 
 
Figure 3. The glpTQ operon showing the TnphoA insertion site. Map based on the 
genome of S. typhimurium LT2 (GenBank Accession NC_003197.1; complement 
(2387000..2392000)). The direction of  glpTQ transcription is opposite that of the 
surrounding genes. 
Evidence for Temperature Regulation of glpQ in S. typhimurium. 
EM876 was originally selected for its increased expression of phoA at 37°C 
compared to 30°C.  It is possible that this difference in expression could be an artifact from 
the loss of GlpQ activity, perhaps due to autogenous regulation of the glpTQ operon.  To test 
for this possibility, alkaline phosphatase assays were performed on EM876 and the 
complemented strain, EM1235. Both EM876 and EM1235 have equal, high phoA activity 
ratios (Figure 4).  Therefore, the loss of GlpQ activity has no effect on the temperature-
dependence of glpQ expression.  In comparison, strain EM1830, which has a TnphoA 
insertion in an unmapped gene, has a low activity ratio, suggesting increased expression at 
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30°C. Other strains with TnphoA fusions that are not temperature-regulated have ratios near 
1.0 (not shown). 
Figure 4. Temperature-dependent alkaline phosphatase expression in Salmonella. 
Mutant strain EM876 and glpQ-complemented mutant, EM1235, have similar PhoA 
expression when grown at 37°C.  Control strain EM1830, conversely, has increased 
expression at 30°C. Error bars represent the standard error of the mean (SEM) of four 
experiments. *, p < 0.05 compared with the EM1830 control. 
Serum Sensitivity of S. typhimurium Strains EM876, EM518, EM1235, and CR7020 
A critical characteristic of strain EM876 is that it displays increased sensitivity to the 
bactericidal effects of serum.  Strain EM876 was derived from the wild-type S. typhimurium 
strain S850 through a series of changes (46).  In brief, a spontaneous streptomycin-resistant 
mutant strain (CR7020) was selected from S850.  This strain was then transduced with a 
phoN mutation linked to a Tn10 insertion.  PhoN is a neutral phosphatase that could 
confound the detection of phoA insertion mutants.  The phoN strain EM518 was then selected 
by growth on Bochner’s medium with the spontaneous excision of the Tn10 (30).  Strain 
EM518 served as the parent of a large set of TnphoA insertion mutants, including EM876.  If 
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the increased sensitivity of EM876 is due to the loss of GlpQ activity, then it should be 
reversed by complementation with the plasmid pLX9610, containing the intact glpTQ 
operon.  Serum killing assays were performed to confirm the increased sensitivity to normal 
human serum of strain EM876, with glpQ interrupted by TnphoA, compared to EM518, the 
parent of EM876, and to the S850 derivative CR7020, with the intact phoN gene.  In these 
assays EM876 was significantly more susceptible to serum than the parental lineage strains 
EM518 and CR7020 (Figure 5).  Importantly, this increased sensitivity was reversed with the 
complementing plasmid in strain EM1235 (EM876/pLX9610).   
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Figure 5. Serum bactericidal assay results showing decreased survival of S. 
typhimurium mutant strain EM876 relative to strains CR7020 (wild-type), EM518 
(EM876 parent strain), and EM1235 (EM876 complimented with glpTQ). Mutant 
EM876 displays a serum-sensitive phenotype, which is reversed with addition of glpTQ 
on a multicopy plasmid. Data are from a two-hour incubation in 90% PNHS. Error 
bars represent the SEM of three experiments. *, p < 0.05 compared with control. 
Construction of Wild-type glpQ Deletion Strains 
The derivation of strain EM876 involved a long series of genetic manipulations that 
could have introduced unintended mutations capable of influencing serum-resistance.  In 
order to confirm that the decrease in serum-resistance in EM876 was due to the disruption of 
glpQ and not to some other cryptic mutation, glpQ deletions were constructed in wild-type 
CR8500 and CR6600 backgrounds. Because bacteriophage P22 is unable to infect EM876, 
P22 transduction could not be used to move the TnphoA insertional mutation in glpQ directly 
from EM876 into the wild-type strains. This necessitated the creation of de novo glpQ 
knockouts. To construct these mutations, the lambda Red system was used to remove only 
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the glpQ gene from CR6600 (TML) and CR8500 (S850), while leaving everything else 
upstream and downstream of glpQ intact. Figure 6 shows the genomic region of S. 
typhimurium LT2 surrounding glpQ and the construction of the glpQ deletion with the 
locations of all primers. 
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Figure 6.  Construction of a glpQ deletion in S. typhimurium LT2. (A.) The genomic 
region surrounding and including the glpTQ operon. (B.) Replacement of glpQ with the 
FRT-cat cassette; glpQ ko fwd/c1 and glpQ ko rev/c2 are PCR primers for the 5’- and 3’-
junctions, respectively; H1 and H2 refer to homologous glpQ flanking regions; P1 and 
P2 are priming sites for amplification of the FRT-cat cassette; FRT is “Flippase-
recognition target”, used to remove the antibiotic-resistance cassette (C.) Removal of 
the antibiotic resistance cassette leaves an 83-nt FRT “scar” site, consisting of P1 and 
P2 (yellow boxes) and one FRT site (orange box), in place of the deleted gene. 
In order to make isogenic glpQ deletion strains of CR6600 and CR8500, the glpQ 
deletion was first made in strain JS198, resulting in EM1282 (JS198 ΔglpQ::cat). JS198 is a 
derivative of S. typhimurium LT2, which is sensitive to bacteriophage P22. Therefore, 
EM1282 was used as the donor for P22 transduction to move the mutation in glpQ into 
CR6600 and CR8500 backgrounds, creating strains EM1287 – EM1292. 
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To ensure that glpQ was replaced by the FRT-cat cassette in EM1282, colony PCR 
was performed with primer sets designed to amplify the 5’- and 3’- FRT-cat cassette junction 
regions, as well as a glpQ internal fragment (Figure 7). 
 
Figure 7. glpQ replacement with FRT-cat cassette in P22 donor strain EM1282 analyzed 
on a 2% agarose gel. The 1 Kb Plus DNA ladder (Invitrogen) was used to estimate 
molecular weight. Amplicon sizes were determined from sequence analysis. 
Primer set glpQ ko forward and c1 were used to amplify the 5’ junction (Figure 6B), 
giving an amplicon of 244 bp and primer set glpQ ko reverse and c2 amplified a 122 bp 
fragment of the 3’ junction. Amplification only occurred if glpQ was replaced by the FRT-
cat cassette. As shown in Figure 7, there are no bands for JS198, which still has glpQ intact. 
To be certain that EM1282 was a glpQ deletion mutant, a third primer set (glpQ internal 
forward and glpQ internal reverse) amplified a 395 bp stretch of DNA near the middle of 
glpQ (Figure 6A). Figure 7 shows that only JS198 still contains the glpQ gene, whereas 
EM1282 shows no amplification. PCR using these primer sets was also performed on 
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transductant strains EM1287 – EM1292, which demonstrated the same pattern of 
amplification (not shown). 
 
Figure 8. Identification of the FRT scar site. 2% agarose gel showing PCR amplicons of 
intact glpQ gene and FRT-cat cassette excision site. Marker is the 1 Kb Plus DNA 
ladder (Invitrogen). 
Following P22 transduction to move the glpQ deletion into new CR8500 and CR6600 
backgrounds (resulting in EM1287, EM1289, EM1290, and EM1292), plasmid pCP20, 
encoding a flippase, was transformed into the transductants to remove the FRT-cat cassette. 
Removal of the antibiotic resistance cassette results in a FRT scar site of 83 bp (14), which 
includes the residual FRT-cat cassette (Figure 5C). PCR using primers flanking the scar site 
was used to confirm the presence of this scar, which resulted in an amplicon of 145 bp 
(Figure 8). The presence of either glpQ or the FRT-cat cassette results in an amplicon of 
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approximately 1100 bp. Strains EM1293 – EM1296 resulted from successful removal of the 
FRT-cat cassette (Figure 8). 
Serum Killing Assays with ΔglpQ Strains 
Serum killing assays were performed to test the serum resistance of the new glpQ 
deletion mutants of CR6600 and CR8500, both alone and with the addition of glpTQ on 
pLX9610. When compared with initial serum killing assays with EM876, the glpQ deletion 
mutants showed decreased survival in serum relative to the wild-type strains. However, when 
the glpQ deletion mutants were complemented with glpTQ on a plasmid, the level of survival 
further decreased, as shown in Figure 9. For the most part, this trend persisted across 
experiments and strains. The only minor exception is seen in the lower right graph in Figure 
9. In this case, EM1294 (ΔglpQ) had the highest survival at 4 and 6 hours, followed by 
EM1298 (ΔglpQ/pLX9610), while the wild-type CR8500 had the lowest survival at 4 and 6 
hours.  
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Figure 9.  Effect of glpQ deletion and complementation in wild-type backgrounds. The 
upper two graphs show the survival of the wild-type strain (○ CR6600), ΔglpQ strains 
(□ EM1295 and □ EM1296), and ΔglpQ/pLX9610 strains (△ EM1299 and △ EM1300). 
The lower two graphs show the survival of the wild-type strain (○ CR8500), ΔglpQ 
strains (□ EM1293 and □ EM1294), and ΔglpQ/pLX9610 strains (△ EM1297 and △ 
EM1298). Error bars represent the SEM of at least three experiments; *, p<0.05; * *, 
p<0.1. 
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DISCUSSION 
 
The purposes of this study were twofold: first, to identify the chromosomal gene 
disrupted by the TnphoA insertion in strain EM876, and second, to investigate the possible 
role the gene might play in temperature-regulated serum-resistance in S. typhimurium. 
Determination of TnphoA Insertion Site 
By employing an inverse PCR technique designed to amplify TnphoA insertion 
junctions, cloning, and DNA sequencing of the cloned inserts, we were able to determine that 
the TnphoA insertion in EM876 was in the gene glpQ, located on the chromosome. This was 
an unexpected finding, as glpQ has not been previously identified as a virulence gene in 
either S. typhimurium or its close relative, E.coli.  Rather, glpQ is a glycerophosphodiester 
phosphodiesterase (GDPD) that is located in the periplasm. Its role in the glycerol 
degradation pathway is converting deacylated phospholipids to glycerol 3-phosphate and the 
corresponding primary alcohol (28). These breakdown products then are transported into the 
cytoplasm of the cell through the GlpT antiporter, encoded by glpT, the first gene in the 
glpTQ operon. Together, the products of the glpTQ operon provide the cell with a source of 
carbon and phosphate, as well as membrane lipid precursors (Figure 10) (27, 29). Although 
glpQ serves primarily as a housekeeping gene, which would not be predicted to be involved 
in virulence, it is being associated with virulence in some bacterial species that are not 
closely related to S. typhimurium or E. coli. In Haemophilus influenzae, a glpQ-encoded 
GDPD is a primary component of the virulence factor, Protein D (16). In this case, however, 
GlpQ is a lipoprotein that is anchored to the outer surface of H. influenzae. It is thought that 
its location outside the bacterial cell allows it to scavenge choline from host cells to use as 
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LPS decoration (17). glpQ in Enterococcus faecalis has been shown to induce intermediate 
resistance to class II bacteriocins by an unknown mechanism (11, 12).  
 
Figure 10. Glycerol 3-phosphate metabolism in E. coli (taken from Larson et al. 1983). 
Evidence of Temperature Regulation 
There is limited evidence in Shigella flexneri to suggest that glpQ is preferentially 
expressed at higher temperatures (37°C vs. 30°C) because it is under H-NS (histone-like 
protein H1) regulation. Under low-temperature conditions, H-NS binding of the regulatory 
region just upstream of the 5’ end of glpT represses transcription of the glpTQ operon. 
However, when there is a temperature upshift, H-NS is released from its binding site and 
transcription can proceed (47). Previous experiments determined that our TnphoA insertional 
mutant, EM876, showed differential gene expression at 37°C vs. 30°C. When the alkaline 
phosphatase assays were repeated using the glpQ-complement strain, EM1235, again there 
was more phoA expression at 37°C than at 30°C. The temperature-dependent regulation of 
the glpQ::TnphoA fusion in EM876 is not altered by the presence of the complementing 
plasmid with the wild-type glpQ (in strain EM1235), suggesting that the temperature-
dependence is not an artifact of the loss of glpQ. 
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In TnphoA insertion mutants, the amount of alkaline phosphatase activity serves as a 
proxy for the expression levels of the gene fused to phoA.  As such, PhoA assays of EM876 
and the complemented strains are an indirect measure of glpQ expression. Having a direct 
measure of glpQ gene expression would be an important confirmation of the data we have 
already collected. RT-PCR (reverse transcriptase PCR) is a widely accepted method of 
measuring gene expression based on transcript (mRNA) levels in real time. Alternatively, 
Northern blot analysis could also be used. 
Serum Killing of EM876 and Controls 
Serum bactericidal assays were conducted with 90% PHNS in 5% CO2 to 
approximate in vivo conditions as much as possible.  After two hours of incubation, EM876 
had about a 30% average decrease in survival in PNHS when compared with the wild-type 
(CR7020) and the parent (EM518).  Previous studies (46) had demonstrated a similar 50% 
reduction in survival. Complementation of EM876 with glpQ on a plasmid (EM1235) 
restored serum-resistance to wild-type levels. These results suggest that the decrease in 
survival of EM876 is due to the disruption of glpQ.  
Construction of Wild-type glpQ Deletion Strains 
EM876, its parent strain EM518, and the complementation strain EM1235 are all in a 
phoN– background to improve the detection of the PhoA activity.  Since these known and 
unknown background mutations might have unanticipated effects on virulence, we 
constructed glpQ knockouts in wild-type S. typhimurium strains, CR8500 and CR6600.  
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Serum Killing Assays with ΔglpQ Strains 
The serum killing assays that were performed with the glpQ deletion mutants 
produced unanticipated results – when ΔglpQ strains were complimented with glpTQ on a 
plasmid, survival in 90% serum was actually reduced rather than restored to wild-type levels. 
Not only was survival in complemented strains reduced, but in most cases it was reduced to 
levels slightly less than that of the actual ΔglpQ strains. The lack of complementation is 
puzzling, especially since the same plasmid, pLX9610, was used in earlier experiments and 
performed as expected. Previous studies in E.coli cloned the glpTQ operon into pBR322 
without any reported expression issues (27, 28). One possible explanation is that somehow 
the deletion of glpQ from the chromosome causes instability of the glpT transcript, resulting 
in a lack of the glycerol 3-phosphate permease or a non-functional protein. In this scenario, 
the ΔglpQ strain would not make sufficient GlpT while it would in the glpQ::TnphoA fusion.  
For this to be consistent with the results, the complementing plasmid copy of glpT would 
have to be nonfunctional in some way.  It is also possible that deletion of glpQ from the 
chromosome has an effect elsewhere in the genome that the complementation plasmid is not 
accounting for and cannot correct.  This might be a cis-acting effect on the divergent glpTQ 
promoter, which appears to overlap the glpA promoter. However, this scenario does not seem 
likely since other members of the glp regulon are not affected by the loss of glpQ function 
(27). It would be interesting to test a different glpQ knockout strain that was generated during 
the course of this study, which has an intron insertion in glpQ rather than a frank glpQ 
deletion (not shown). Performing serum-killing assays with this glpQ intron insertion mutant 
might answer the question of whether the current lack of complementation is a result of 
chromosomal glpQ deletion. A glycerophosphodiesterase assay for the presence of the GlpQ 
protein may also be informative. This assay could determine which strains were actually 
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producing the protein and roughly how much of it they were producing; this may help in 
trouble-shooting the problems with complementation. 
Colony Phenotypes 
During the course of experimentation, differences in colony morphology were 
observed between wild-type Salmonella and some of the mutant strains generated in this 
study. The normal colony morphology for the wild-type strains, EM876, and all the ΔglpQ 
strains consists of medium-sized, round, convex, ivory-colored colonies as seen in Figure 
11A. 
 A.   B.  
Figure 11.  Colony morphologies.  (A) Normal opaque colony morphology.  (B) Mixed 
colony morphologies with both opaque and translucent colonies. 
In contrast, all of the strains containing the complementation plasmid, pLX9610, had 
two different colony phenotypes (Figure 11B). Overall, the colonies were smaller than 
normal and irregularly shaped.  Nearly half the colonies have a raised margin and are 
somewhat translucent, while the other half are opaque and have a wrinkled surface. There are 
also single colonies that appear to have both phenotypes. The only minor difference between 
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the complemented strains was that EM1235 appeared to have a predominance of the 
translucent colony phenotype over the opaque phenotype (approximately 80% vs. 20%).  
Taking a single colony from the plate in Figure 11B and streaking for isolation on 
fresh media produced the same mix of colony morphologies. This happened no matter which 
phenotype the starting colony displayed, which suggests that all of the colonies with 
alternative phenotypes encode the factor or factors that produce both morphologies. In 
addition, EcoRI restriction analysis performed on plasmid DNA isolated from each colony 
type confirmed the presence of pLX9610. 
Interestingly, survivors of the serum-killing experiments showed no phenotypic 
differences at all. All of the colonies showed the morphology as seen in Figure 11A.  One 
interpretation of this observation is that the failure of the glpQ complementing plasmid to 
restore serum-resistance to ΔglpQ strains is due to the generation of an altered (translucent) 
colony phenotype that is more serum-sensitive than the normal (opaque) colony morphotype. 
The source of the colony dimorphism is likely to be pLX9610, since only strains 
complemented with this plasmid show this trait.  These differences in morphology are 
consistent with changes in the protein constituents of membranes. There is evidence that 
Protein II phase variants of Neisseria can switch between opaque and translucent colony 
phenotypes (5). It is unknown, however, what physiologic difference or specific genetic 
mechanism are causing these changes in the S. typhimurium colony appearance.  The high 
and consistent frequency of these morphological types is consistent with phase variation (7) 
or, perhaps, a dysfunctional regulatory process. There is a report in E. coli of the 
development of opaque and translucent colony morphologies as a result of overexpression of 
a cloned protein (2). It is possible that cloning the glpTQ operon into a high copy vector 
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raises gene expression to a toxic level. It may be worth cloning the glpTQ operon into 
medium and low copy vectors to evaluate how well they can complement the deletion or 
disruption of glpQ. Using a low copy vector would also reduce the likelihood of unwanted 
homologous recombination with the chromosome. In any case, the effects could be 
pleiotrophic and extend beyond the glpTQ and glpA operons.  
This study has demonstrated for the first time a possible relationship between glpQ 
and virulence in Salmonella typhimurium. Results from alkaline phosphatase assays strongly 
suggest differential expression of glpQ at higher temperatures. This is consistent with the fact 
that genes encoding virulence traits are often temperature-regulated (22). Results from serum 
killing assays are less clear. However, there is a consistent decrease in serum resistance when 
glpQ is deleted from the chromosome, which indicates that glpQ is likely promoting 
increased survival in serum by an unknown mechanism. Previous work has shown that the 
traT gene located on the virulence plasmid is also temperature-regulated and responsible for 
serum-resistance (46). Interestingly, there is possible evidence in Shigella flexneri that 
crosstalk between the virulence plasmid and the chromosome regulates virulence 
determinants (47). The study found that upon curing out the virulence plasmid, genes of the 
glp regulon, particularly glpQ, were upregulated. It is not known how the virulence plasmid 
and chromosome work together to regulate virulence, but it is possible that housekeeping 
genes like glpQ act as global regulators that support virulence functions (45). The idea of 
housekeeping genes as “virulence life-style genes” (45) is becoming more prevalent as 
researchers move toward a more holistic view of bacterial pathogenesis, in which regulatory 
elements and genes involved in metabolism are coming to the forefront. This study adds to 
the growing body of evidence that is redefining housekeeping and virulence genes. 
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